Table 3.
Recommended treatments for adult outpatients of M. pneumoniae pneumonia.
| Drug | Route of administration | mg/dose | Dose/day | |
|---|---|---|---|---|
| First-line drug | Clarithromycin (CAM) | Oral | 200 | 2 |
| Azithromycin (AZM) (Slow-release formulation) | Oral | 2000 | 1 (1 day) | |
| Azithromycin (AZM) | Oral | 500 | 1 (3 days) | |
| Erythromycin (EM) | Oral | 200 | 4–6 | |
| Second-line drug | Minocycline (MINO) | Oral | 100 | 2 |
| Levofloxacin (LVFX) | Oral | 500 | 1 | |
| Garenoxacin (GRNX) | Oral | 400 | 1 | |
| Moxifloxacin (MFLX) | Oral | 400 | 1 | |
| Sitafloxacin (STFX) | Oral | 100 | 2 | |
| Oral | 200 | 1 | ||
| Tosufloxacin (TFLX) | Oral | 150 | 2–3 |
The table is adapted from the guiding principle (Chiryo–Shishin) issued by the Japanese Society of Mycoplasmology (JSM). http://square.umin.ac.jp/jsm/shisin.pdf.